PHAXIAM Therapeutics S.A. (PHXM) — Free Cash Flow Generation Index

Latest as of December 2012: 1.08x

PHAXIAM Therapeutics S.A. (PHXM) has a Free Cash Flow Generation Index of 1.08x as of December 2012. Free cash flow of €669.80K represents 1% of operating cash flow (€621.40K). See working capital to net assets of PHAXIAM Therapeutics S.A. to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.08x

Free Cash Flow / Operating CF

Free Cash Flow

€669.80K

EUR

Operating Cash Flow

€621.40K

EUR

Capital Expenditures

€48.40K

EUR

PHAXIAM Therapeutics S.A. Free Cash Flow Generation Index (2012–2012)

Historical FCF Generation Index trend for PHAXIAM Therapeutics S.A. across 1 annual periods. Explore PHAXIAM Therapeutics S.A. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for PHAXIAM Therapeutics S.A. (2012–2012)

Year-by-year Free Cash Flow Generation Index for PHAXIAM Therapeutics S.A.. For the full company profile including market capitalisation, see PHAXIAM Therapeutics S.A. (PHXM) total market value.

Year	FCG Index	Free Cash Flow (EUR)	Operating CF	Capital Expenditures	YoY Change
2012	0.92x	€568.90K	€621.40K	€52.50K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).